DARA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
DARA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
DARA Biosciences's total inventories for the quarter that ended in Sep. 2015 was $0.27 Mil. DARA Biosciences's average total inventories from the quarter that ended in Jun. 2015 to the quarter that ended in Sep. 2015 was $0.22 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. DARA Biosciences's Net-Net Working Capital per share for the quarter that ended in Sep. 2015 was $0.11.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory. DARA Biosciences's Days Inventory for the three months ended in Sep. 2015 was 83.87.
Inventory Turnover measures how fast the company turns over its inventory within a year. DARA Biosciences's Inventory Turnover for the quarter that ended in Sep. 2015 was 1.09.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. DARA Biosciences's Inventory-to-Revenue for the quarter that ended in Sep. 2015 was 0.19.
The historical data trend for DARA Biosciences's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DARA Biosciences Annual Data | |||||||||||||||||||||
Trend | Dec05 | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | |||||||||||
Total Inventories | Get a 7-Day Free Trial | - | - | 0.13 | 0.10 | 0.27 |
DARA Biosciences Quarterly Data | ||||||||||||||||||||
Dec10 | Mar11 | Jun11 | Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | |
Total Inventories | Get a 7-Day Free Trial | 0.24 | 0.27 | 0.20 | 0.18 | 0.27 |
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
DARA Biosciences (NAS:DARA) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
DARA Biosciences's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2015 is
Net-Net Working Capital Per Share (Q: Sep. 2015 ) | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (4.659 | + | 0.75 * 1.151 | + | 0.5 * 0.267 | - | 3.513 |
- | 0 | - | 0) | / | 19.7556 | ||
= | 0.11 |
2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
DARA Biosciences's Days Inventory for the three months ended in Sep. 2015 is calculated as:
Days Inventory | = | Average Total Inventories (Q: Sep. 2015 ) | / | Cost of Goods Sold (Q: Sep. 2015 ) | * | Days in Period |
= | 0.2215 | / | 0.241 | * | 365 / 4 | |
= | 83.87 |
3. Inventory Turnover measures how fast the company turns over its inventory within a year.
DARA Biosciences's Inventory Turnover for the quarter that ended in Sep. 2015 is calculated as
Inventory Turnover | = | Cost of Goods Sold (Q: Sep. 2015 ) | / | Average Total Inventories (Q: Sep. 2015 ) |
= | 0.241 | / | 0.2215 | |
= | 1.09 |
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
DARA Biosciences's Inventory to Revenue for the quarter that ended in Sep. 2015 is calculated as
Inventory-to-Revenue | = | Average Total Inventories (Q: Sep. 2015 ) | / | Revenue (Q: Sep. 2015 ) |
= | 0.2215 | / | 1.181 | |
= | 0.19 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Thank you for viewing the detailed overview of DARA Biosciences's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
David Drutz | director, officer: Executive Chairman and CMO | 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615 |
David L. Tousley | officer: CFO | 14610 PAWNEE LANE, LEAWOOD KS 66224 |
Gail Lieberman | director | 175 EAST 79TH STREET, APT. 4D, NEW YORK NY 10075 |
Paul John Richardson | director | 17 COUNTRY OAKS ROAD, LEBANON NJ 08833 |
Steve Gorlin | director | 150 GULF SHORE DRIVE, UNIT 601, DESTIN FL 32541 |
Ann A Rosar | officer: Vice President Finance | C/O 801 CAPITOLA DRIVE, DURHAM NC 27713 |
John C Thomas | director | 8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615 |
Geert Cauwenbergh | director | 1 STULTS DRIVE, PLAINSBORO NJ 08536 |
Kurt M Eichler | director | C/O SPRING BANK PHARMACEUTICALS, INC., STE S-7, MILFORD MA 01757 |
Hamilton Jordan | director | |
Stuart C Mcwhorter | director | 113 SEABOARD LANE, FRANKLIN TN 37067 |
Timothy J Barberich | director | 40 ELM ST, CONCORD MA 01752 |
Michael P Duffy | officer: SVP, GC and Secretary | C/O POINT THERAPEUTICS INC, 125 SUMMER STREET SUITE 1840, BOSTON MA 02110 |
Richard J Benjamin | director | 15 WHITE PINE ROAD, NEWTON MA 02464 |
Larry G Pickering | director | 26130 MANDEVILLA DRIVE, BONITA SPRINGS FL 34134 |
From GuruFocus
By gurufocus 10qk • 05-14-2010
By gurufocus • 05-16-2009
By gurufocus • 08-14-2009
By gurufocus 10qk • 08-13-2010
By gurufocus 10qk • 11-13-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.